Bateman NW, Tarney CM, Abulez TS, Hood BL, Conrads KA, Zhou M, Soltis AR, Teng PN, Jackson A, Tian C, Dalgard CL, Wilkerson MD, Kessler MD, Goecker Z, Loffredo J, Shriver CD, Hu H, Cote M, Parker GJ, Segars J, Al-Hendy A, Risinger JI, Phippen NT, Casablanca Y, Darcy KM, Maxwell GL, Conrads TP and O’Connor TD. Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry. iScience 2022;25(1):103665.10.1016/j.isci.2021.103665.
Darmon S, Park A, Lovejoy L, Shriver CD, Zhu K and Ellsworth RE. Relationship between Cigarette Smoking and Cancer Characteristics and Survival among Breast Cancer Patients. Int. DJ. Environ. Res. Public Health 2022;2022(19, 4084)10.3390/ijerph19074084.
Maisel BA, Yi M, Peck AR, Sun Y, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Nevalainen MT, Tanaka T, Simone N, Wang LL, Rui H and Chervoneva I. Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer. Cancers (Basel) 2022;14(2)10.3390/cancers14020308.
Somiari SB, Shuss S, Liu J, Mamula K, O’Donnell A, Deyarmin B, Kane J, Greenawalt A, Larson C, Rigby S, Hu H and Shriver CD. Assessing the quality of RNA isolated from human breast tissue after ambient room temperature exposure. PLoS One 2022;17(1):e0262654.10.1371/journal.pone.0262654.
Yu P, Kazemier G, Brandlund I, Tasneem A, Wiberg H, Wesdorp NJ, Lambrecht M, Hu H, Winn RA, Kearney S, Huiskens J and Granger E. Artificial intelligence comes of age in the fight against cancer. Oncology Times 2022;44(3):1,15-16.
Zhang A and Hu H. A novel blood-based microRNA diagnostic model with high accuracy for multi-cancer early detection. Cancers 2022;14(6):1450.
Lin J, Hu H, Shriver CD and Zhu K. Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program. Clin Breast Cancer 2021;10.1016/j.clbc.2021.11.010.
Lovejoy LA, Rummel SK, Turner CE, Shriver CD and Ellsworth RE. Frequency and spectrum of mutations across 94 cancer predisposition genes in African American women with invasive breast cancer. Fam Cancer 2021;20(3):181-187.
Lovejoy LA, Turner CE, Shriver CD and Ellsworth RE. Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness. Mil Med 2021;186(7-8):e737-e742.
Bera A, Russ E, Srinivasan M, Eidelman O, Eklund M, Hueman M, Pollard HB, Hu H, Shriver CD and Srivastava M. Proteomic Analysis of Inflammatory Biomarkers Associated With Breast Cancer Recurrence. Mil Med 2020;185(Supplement_1):669-675.10.1093/milmed/usz254.
Bera A, Subramanian M, Karaian J, Eklund M, Radhakrishnan S, Gana N, Rothwell S, Pollard H, Hu H, Shriver CD and Srivastava M. Functional role of vitronectin in breast cancer. PLoS One 2020;15(11):e0242141.10.1371/journal.pone.0242141.
Lovejoy L, Turner C, Wells JM, Shriver CD and Ellsworth R. Hertability of Low ER Staining/Her2-Breast Tumors: Are We Missing an Opportunity for Germline Testing? Genes 2020;2020(11)10.3390/genes1112149.
Odnokoz O, Yu P, Peck AR, Sun Y, Kovatich AJ, Hooke JA, Hu H, Mitchell EP, Rui H and Fuchs SY. Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancers. Cancer Biol Ther 2020:1-8.10.1080/15384047.2020.1750297.
Rummel S, Lovejoy L, Turner C, Shriver CD and Ellsworth RE. Should genetic testing or cancer predisposition be standard-of-care for women with invasive breast cancer? The Murtha Cancer Center Experience. Cancers 2020;2020(12, 234)10.3390/cancers 12010234.
Sturtz LA, Wang G, Shah P, Searfoss R, Raj-Kumar PK, Hooke JA, Fantacone-Campbell JL, Deyarmin B, Cutler ML, Sarangarajan R, Narain NR, Hu H, Kiebish MA, Kovatich AJ and Shriver CD. Comparative analysis of differentially abundant proteins quantified by LC-MS/MS between flash frozen and laser microdissected OCT-embedded breast tumor samples. Clin Proteomics 2020;17(1):020-09300.
Zhang Y, Liu J, Raj-Kumar PK, Sturtz LA, Praveen-Kumar A, Yang HH, Lee MP, Fantacone-Campbell JL, Hooke JA, Kovatich AJ, Shriver CD and Hu H. Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer. Breast Cancer Res Treat 2020;10.1007/s10549-020-05884-z.